Determining the repeatability of measurements in metastatic prostate cancer using prostate-specific PET scan imaging
Not Applicable
Recruiting
- Conditions
- Prostate CancerCancer - Prostate
- Registration Number
- ACTRN12620001110976
- Lead Sponsor
- Sir Charles Gairdner Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
•Metastatic prostate cancer with evidence of PSA progression
•No change in prostate cancer specific treatment in the previous 12 weeks.
•Males greater than 18 years old.
•Able to provide informed consent and undergo study procedures.
Exclusion Criteria
•Unable to provide informed consent.
•Other active neoplastic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method